Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

Abstract

KTx can be successfully performed in AL patients in complete hematologic response and meet the usual KTx selection criteria. Outcomes appear similar whether hematologic response was achieved with ASCT or by nonmyeloablative therapy.